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Low-Energy Visible Light Irradiation Modulates
Immune Responses Induced by Epicutaneous
Sensitization with Protein Antigen
Jau-Shiuh Chen1, Hsien-Ching Chiu1, Chih-Jung Hsu1, Ching-Yi Liu1, Pei-Chen Hsieh1, Shi-Chuen Miaw2,
Hsin-Su Yu3 and Li-Fang Wang1
Epicutaneous sensitization has been an important route for protein allergen sensitization in atopic disease.
Although the skin is irradiated by sunlight daily, the influence of visible light on epicutaneous sensitization has
not been explored. In this study, by using a well-established murine protein-patch model, we show that low-
energy visible light (LEVL) irradiation could differentially modulate the predominant Th2 immune response
induced by epicutaneous sensitization with protein antigen. When the induced Th2 response was strong, as
usually observed in BALB/c mice, LEVL irradiation suppressed the response. In contrast, LEVL irradiation
enhanced the weaker Th2 response in C57BL/6 mice. Increased IL-18 and decreased TGF-b expression in
draining lymph nodes after LEVL irradiation was observed in BALB/c mice, but not in C57BL/6 mice. LEVL
irradiation also enhanced IL-18 expression in skin and reduced the downregulation of CD24 expression on
epidermal Langerhans cells in draining lymph nodes of BALB/c mice. Collectively, these results provide
evidence for immunomodulatory effects of LEVL irradiation and will help us develop a useful strategy for
prevention of allergen sensitization.
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INTRODUCTION
Life on earth is radiated by sunlight daily. Previous studies
have focused on the effects of ultraviolet (UV) radiation of
sunlight, whereas studies on the effects of visible light have
been sparse. UV light elicits many biological effects, such as
immunomodulation, skin aging, and carcinogenesis (Ullrich,
2005). The development of a helium-neon laser, which
delivers red light at a wavelength of 633 nm, has spurred the
discovery of some biological effects of low-energy visible
light (LEVL). Clinically, LEVL irradiation has beneficial effects
on wound healing and recovery of nerve injury (Lipovsky
et al., 2008). Our group has reported that LEVL irradiation
induces repigmentation in segmental-type vitiligo (Yu et al.,
2003). In vitro studies have shown that LEVL irradiation
increases the motility of cultured human keratinocytes and
stimulates their secretion of IL-1a and IL-8 (Haas et al., 1990;
Yu et al., 1996). LEVL also enhances migration, proliferation,
and growth factor release of melanocytes (Yu et al., 2003).
The underlying mechanisms of bio-modulation by LEVL
irradiation are still unclear, although it has been reported that
cytochrome c oxidase serves as a photoreceptor, and
induction of reactive oxygen species and increase in
intracellular calcium concentration are involved (Karu,
1999; Lavi et al., 2003).
The prevalence of atopic disease has progressively
increased in the past few decades. The interactions of genetic
susceptibility to atopy with various environmental protein
allergen exposures play a central role in the pathogenesis of
atopic diseases (Ngoc et al., 2005). Atopic dermatitis (AD) is
often the first manifestation of the atopic triad and is the
beginning of the ‘‘atopic march’’ (Spergel and Paller, 2003).
The route of protein allergen sensitization in AD patients is
still unclear. However, compelling clinical evidence suggests
that epicutaneous exposure to protein allergens is one of the
important sensitization routes for AD (Santamaria Babi et al.,
1995; Teraki et al., 2000). In animal models, we and others
have demonstrated that epicutaneous sensitization with
protein antigens induces a predominant Th2 and a weak
Th1 response, which lead to AD-like skin lesions and
development of asthma (Wang et al., 1996; Spergel et al.,
1998). An epicutaneously induced Th2 immune response
requires the production and secretion of IL-10 and IL-13
(Herrick et al., 2003; Laouini et al., 2003). Downregulation of
the epicutaneously induced Th2 response has been mediated
by cyclooxygenase-2 in an animal model (Laouini et al.,
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2005). As human skin is irradiated daily by visible light, we
investigated the influence of LEVL irradiation on the immune
response induced by epicutaneous sensitization with protein
antigen.
RESULTS
Low-energy visible light irradiation suppresses the Th2 immune
response induced by epicutaneous sensitization with protein
antigen in BALB/c mice
The irradiation dose used in previous reports regarding LEVL
irradiation was quite variable. Most investigators used
0.1–10 J cm2 as the range of irradiation doses. Hence, we
chose 4.8 J cm2 for our experiments (as described in
Materials and methods, mice received LEVL irradiation for
20minutes by LED at 0.04mW at 10 cm distance). BALB/c
mice were divided into three groups. One group received
LEVL irradiation immediately before OVA patch application
successively for 5 days. Another group of mice received
similar treatment but without prior LEVL irradiation. A group
that received a PBS patch application served as negative
control. The cytokine contents of the supernatants from
in vitro OVA reactivation cultures were chosen as indicators
of Th immune response. IL-5 and IL-13 represent the Th2
immune response, and IFN-g represents the Th1 immune
response. As expected, epicutaneous sensitization with OVA
induced a predominant Th2 and a weak Th1 immune
response in the sham-irradiated group, as indicated by high
IL-5 and IL-13 as well as low IFN-g contents in the culture
supernatants (Figure 1). When the LEVL-irradiated group was
compared to the sham-irradiated group, it showed much
lower IL-5 and IL-13 contents in the supernatant. However,
LEVL irradiation did not modulate Th1 induction, as IFN-g
content from the LEVL-irradiated group was similar to that of
the sham-irradiated group (Figure 1). Thus, we conclude that
LEVL irradiation has a suppressive effect on the Th2 response
induced by epicutaneous sensitization with protein antigen in
BALB/c mice without modulating the Th1 response.
LEVL irradiation has differential effects on Th2 immune
response induced by epicutaneous sensitization in BALB/c and
C57BL/6 mice
BALB/c mice are genetically Th2-prone and have been used
as an experimental model for human atopy. By contrast,
C57BL/6 mice are Th1-prone and used for human non-atopy.
To assess if the suppressive effect of LEVL irradiation on the
Th2 immune response observed in BALB/c mice also existed
in C57BL/6 mice, similar experiments were performed in
C57BL/6 mice. As expected, epicutaneous sensitization with
OVA induced less IL-5 and IL-13 production in the OVA
reactivation culture from C57BL/6 mice (Figure 2a). How-
ever, to our surprise, C57BL/6 mice receiving LEVL irradia-
tion showed higher, not lower, concentrations of IL-5 and
IL-13 in the supernatants than did the sham-irradiated group
(Figure 2a). The levels of IFN-g production were similar in the
LEVL-irradiated and in the sham-irradiated group. Similar
differential effects of LEVL irradiation were observed when
BALB/c and C57BL/6 mice were epicutaneously immunized
simultaneously (data not shown).
To further explore this dilemma, the TLR-2 agonist, a well-
known Th2 enhancer, was employed. As expected, C57BL/6
mice receiving co-administration of OVA plus Pam3CSK4
and sham irradiation showed higher IL-5 and IL-13 contents
in their culture supernatants (Figure 2b). However, C57BL/6
mice that received LEVL irradiation and co-administration of
OVA plus Pam3CSK4 showed decreased IL-5 and IL-13
contents compared to sham-irradiated mice. The IFN-g
contents were again similar in sham-irradiated and LEVL-
irradiated groups of C57BL/6 mice. Taken together, these
results demonstrate that LEVL irradiation has differential
effects on the Th2 immune response induced by epicuta-
neous sensitization with protein antigen in BALB/c and
C57BL/6 mice.
LEVL irradiation increases IL-18 and decreases TGF-b
expression in draining lymph nodes in BALB/c mice but not
in C57BL/6 mice
As priming of naive T cells occurs in draining lymph nodes,
we next explored the underlying mechanisms of the
differential effects of LEVL irradiation by comparing the
cytokine expression profiles in draining lymph nodes from
both BALB/c and C57BL/6 mice. As shown in Figure 3, the
expression of IL-18 was comparable in draining lymph nodes
of naive BALB/c and C57BL/6 mice. Three days after
epicutaneous sensitization with OVA, IL-18 expression was
always lower in the sham-irradiated group of BALB/c mice
compared to that of the C57BL/6 mice. However, LEVL
irradiation enhanced the IL-18 expression in BALB/c mice but
not in C57BL/6 mice. Moreover, 3 days after immunization,
the TGF-b expression level in draining lymph nodes (LNs) of
the LEVL-irradiated group of BALB/c mice was always lower
than in the sham-irradiated group (Figure 3). A similar
decrease was not observed in C57BL/6 mice. The change in
IL-18 and TGF-b expression is small in amplitude but
significant, because we have repeated the experiments at
least three times and similar results were always observed.
We also checked the IL-18 and TGF-b expression levels in
BALB/c and C57BL/6 mice 2 and 4 days after epicutaneous
immunization; similar trends with less amplitude were
observed (data not shown). The expression of IFN-g,
IL-12(p35), IL-12(p40), IL-4, IL-10, IL-6, IL-1a, IL-1b, TNF,
IFN-a, and IFN-b in draining LNs was very low or
undetectable and showed no significant differences between
LEVL-irradiated and sham-irradiated groups in either BALB/c
or C57BL/6 mice (data not shown). Collectively, these data
reveal that the differential effects of LEVL irradiation correlate
with the expression of IL-18 and TGF-b in draining lymph
nodes of BALB/c and C57BL/6 mice.
LEVL irradiation increases IL-18 expression in skin and reduces
the downregulation of CD24 expression on epidermal
Langerhans cells in draining lymph nodes of BALB/c mice
As LEVL irradiation had modulated the strong Th2 immune
response induced by epicutaneous sensitization with protein
antigen in BALB/c mice, we explored its effects on the skin of
BALB/c mice. First, cytokine expression profiles of skin from
LEVL- and sham-irradiated mice were compared. As shown
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Figure 1. Low-energy visible light (LEVL) irradiation suppresses the epicutaneously induced Th2 immune response in BALB/c mice. Groups of BALB/c
mice (n¼ 5) were immunized by patch application with OVA solution or PBS control. For the LEVL group, mice received LEVL irradiation immediately before
patch application. Ten days later, draining LNs were obtained and the IFN-g, IL-5, and IL-13 contents of the supernatants of the in vitro OVA reactivation culture
of the pooled draining LN cells were determined by ELISA. Net concentrations (concentration in the absence of OVA subtracted from concentration in the
presence of OVA) are presented. Three independent experiments were performed with similar results. Data from one representative experiment are shown.
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Figure 2. LEVL irradiation has differential effects on strong and weak Th2 immune responses induced by epicutaneous sensitization. Groups of C57BL/6 mice
(n¼5) were immunized by patch application with OVA solution or PBS control (a) or OVA plus Pam3CSK4 (b). The LEVL group received irradiation
immediately before patch application. Ten days later, draining lymph nodes were obtained and IFN-g, IL-5, and IL-13 contents of the supernatants of the in vitro
OVA reactivation culture of the pooled draining LN cells were determined by ELISA. Net concentration is presented. Three independent experiments were
performed with similar results. Data from one representative experiment are shown.
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Figure 3. LEVL irradiation induced increased IL-18 and decreased TGF-b expression in draining LNs in BALB/c but not in C57BL/6 mice. Groups of BALB/c
and C57BL/6 mice were immunized by patch application with OVA solution either with prior LEVL irradiation (LEVL) or not (sham).Naive mice received no
treatment. Draining lymph nodes were obtained 72 hours after the start of immunization. Total RNA extraction, cDNA preparation, and quantitative real-time
PCR for various cytokines were performed. The relative cytokine mRNA expression of each group was normalized to its b-actin expression. Results are shown as
fold of the expression level of the naive BALB/c group. Similar results were obtained from three independent experiments. Results from one representative
experiment are shown.
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in Figure 4a, IL-18 expression was detected in skin from naive
and sham-irradiated BALB/c mice at 8 and 24 hours after
epicutaneous sensitization with OVA. LEVL irradiation
increased IL-18 expression in BALB/c skin at 8 and 24 hours
post-sensitization. Again, the increased amplitude was small
but significant, because repeated experiments always got
similar results. The mRNA expression levels of TGF-b, TNF-a,
IL-1a, IL-1b, IFN-g, IL-4, IL-10, IL-12(p35), IL-12 (p40), IL-6,
IFN-a, and IFN-b in skin were very low or undetectable and
showed no significant differences between LEVL-irradiated
and sham-irradiated groups (data not shown).
As IL-18 has been reported to be a key proximal mediator
of Langerhans cell (LC) migration, and UV light irradiation
has been shown to influence their migration (Antonopoulos
et al., 2007), we analyzed the kinetics and characteristics of
skin-derived migratory dendritic cells (DCs) in draining
lymph nodes. Skin-derived migratory DCs in the draining
lymph nodes express the highest level of MHC class II
molecule and have been divided into two subsets based on
intracellular Langerin expression (Villadangos and Schnorrer,
2007). Langerinhigh and Langerin skin-derived DCs in
draining lymph nodes have long been accepted as epidermal
LCs and dermal DCs, respectively (Villadangos and
Schnorrer, 2007). Recently, several groups reported a subset
Langerinhigh DC population, which resides in the dermis and
shows characteristics and migratory kinetics different from
those of epidermal LCs (Bursch et al., 2007; Poulin et al.,
2007). Dermal Langerinhigh DCs arrive at draining nodes
significantly earlier than epidermal LCs after epicutaneous
sensitization (Shklovskaya et al., 2008). The peak influx of
dermal Langerinhigh DCs and epidermal LCs in draining
lymph nodes is at 24 and 96 hours post-immunization,
respectively. Thus, the cellular influx in the draining LNs
was measured at 24 and 96 hours post epicutaneous
sensitization with OVA. As shown in Figure 4b, the numbers
and percentages of MHC class IIhigh DCs in draining LNs,
which represent skin-derived DCs, were comparable in
sham-irradiated and LEVL-irradiated groups of BALB/c mice.
Moreover, the numbers and percentages of Langerinhigh DCs
in draining LNs 24 and 96 hours post-immunization, which
represent dermal Langerinþ DCs and epidermal LCs,
respectively, were also similar between the sham-irradiated
and the LEVL-irradiated group.
To further examine the LEVL effect on the activation of
DCs, the surface expression of costimulatory molecules,
including CD80, CD86, CD54, CD24, and CD40, on
Langerinhigh DCs was compared between the sham-irradiated
and the LEVL-irradiated group. No significant differences in
expression levels of CD80, CD86, CD54, CD24, and CD40
between the sham-irradiated and the LEVL-irradiated group
24 hours after immunization were detected (data not shown).
Interestingly, the expression of CD24 on Langerinhigh DCs in
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Figure 4. Effect of LEVL irradiation on skin and DCs in draining LNs in BALB/c mice (a–c). Groups of BALB/c mice were immunized by patch application
with OVA solution either with prior LEVL irradiation (LEVL) or without (sham). Naive mice received no treatment. (a) 8 and 24hours after patch application,
skin was obtained and quantitative real-time PCR for various cytokines was performed. Similar results were obtained from three independent experiments.
Results from one experiment are shown. (b) 24 and 96 hours after patch application, draining LNs were obtained and prepared for positive selection for DCs.
Intracellular staining for Langerin and surface staining for MHC class II and CD11c were performed. CD11cþ cells were gated. The results are shown as numbers
per mouse as well as ratio in total CD11cþ cells. (c) 96 hours after patch application, intracellular staining for Langerin and surface staining for various
costimulatory molecules were performed. Langerinhigh cells were gated. The expression level of CD24 is shown. LEVL group (gray, dashed line), Sham group
(black), and isotype control (gray, dotted line).
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draining lymph nodes 96 hours after immunization was
always lower in sham-irradiated mice (MFI¼ 392) than in
naive mice (MFI¼575) (data not shown). However, the LEVL
group always showed reduced CD24 downregulation
(MFI¼ 504) compared with the sham-irradiated group
(MFI¼ 392) (Figure 4c). The expression of CD80, CD86,
CD54, and CD40 was similar in sham-irradiated and LEVL-
irradiated groups 96 hours post-immunization. Thus, we
conclude that LEVL increased IL-18 expression in skin and
reduced the downregulation of CD24 expression on epider-
mal LCs in draining LNs after epicutaneous sensitization with
protein antigen.
DISCUSSION
In this study, we demonstrated that LEVL could modulate a
Th2 immune response induced by epicutaneous sensitization
with protein antigen. When the induced Th2 immune
response was strong, as usually observed in Th2-prone
BALB/c mice, LEVL irradiation suppressed it. In contrast, an
epicutaneously induced weaker Th2 response usually ob-
served in Th1-prone C57BL/6 mice was enhanced by LEVL
radiation. The increased IL-18 and decreased TGF-b expres-
sion observed in draining lymph nodes of BALB/c, but not
C57BL/6, mice correlated with the differential effects of LEVL
irradiation. We also showed that LEVL irradiation increased
IL-18 expression in irradiated skin and reduced the down-
regulation of CD24 expression on epidermal LCs in draining
LNs of BALB/c mice. To our knowledge, this effect of LEVL
irradiation on protein allergen sensitization of atopic diseases
has not been reported previously.
IL-18 is structurally homologous to IL-1 and is also
synthesized as a precursor that becomes active after cleavage
with caspase-1 (Nakanishi et al., 2001). IL-18 has many
known effects that might contribute to immunomodulation by
low-energy visible light (summarized in Table 1). IL-18 is a
potent proinflammatory cytokine in innate immunity that
contributes to many pathophysiological inflammatory condi-
tions. For example, active IL-18 has been demonstrated in
patients with Crohn’s disease and a mouse colitis model
(Kanai et al., 2001). Daily treatment with IL-18 and IL-12 has
induced severe colitis and mortality in mice and was
independent of T cells (Nakamura et al., 2000). In adaptive
immunity, IL-18 is unique in that it produces opposite effects
on T cells, depending on the presence or absence of IL-12.
IL-18 enhances the IL-12-driven Th1 immune response,
whereas it stimulates the Th2 immune response in the
absence of IL-12 (Nakanishi et al., 2001).
In our protein-patch model, because we could detect
comparable low-levels of IL-12 expression in draining lymph
nodes of immunized BALB/c and C57BL/6 mice (data not
shown), we suggest the following hypothesis. First, higher
IL-18 expression in immunized C57BL/6 mice cooperates
with low-level IL-12 to enhance the epicutaneously induced
Th1 response, which in turn suppresses the predominant Th2
response. Thus, differential IL-18 expression in draining
lymph nodes after immunization may contribute to the high
and low intensity of the Th2 response observed in BALB/c
and C57BL/6 mice. Second, because LEVL irradiation
enhanced IL-18 expression in draining lymph nodes of
immunized BALB/c mice, the above-mentioned mechanism
may operate to suppress the strong Th2 response induced in
BALB/c mice. The weak point in this hypothesis is that we did
not detect increased IFN-g production in culture supernatants
from C57BL/6 mice or from the LEVL-irradiated group of
BALB/c mice. Our explanation is that the enhancement of the
Th1 response is below the detectable limit of the in vitro
assay, whereas a more sensitive biological effect could reflect
the change. Nevertheless, because we could not detect any
significant change in the expression levels of all measured
cytokines in draining LNs of C57BL/6 mice after LEVL
irradiation, the mechanism by which LEVL irradiation
enhanced the epicutaneously induced Th2 response in
C57BL/6 mice is still elusive. IL-18 has been reported to
promote migration of epidermal LCs into draining LNs by
a TNF-a- and IL-1b-dependent mechanism (Antonopoulos
et al., 2007). However, in our study, we did not detect any
significant differences in the kinetics of migration of skin-
derived DCs into draining lymph nodes between the sham-
and the LEVL-irradiated group of BALB/c mice. One possible
reason is the lack of induction of IL-1b and TNF-a after LEVL
irradiation, because the effect of IL-18 on migration of
epidermal LCs was mediated by these two cytokines.
Moreover, IL-18 has been reported to upregulate CD54,
CD83, CD86, and MHC class II expression on human DCs in
in vitro studies (Gutzmer et al., 2003). The discrepancy
between our results and the previous report regarding the
expression of CD54, CD86, and MHC class II may be
attributed to differences between in vivo and in vitro systems
and between different subsets of DCs. The information about
CD24 as a costimulatory molecule has been sparse (Enk and
Katz, 1994). As epicutaneous sensitization with protein
antigen induces a remarkable downregulation of CD24
expression on epidermal LCs in draining LNs, and epidermal
LCs have been suggested to mediate the Th2 immune
response, reduced downregulation of CD24 expression might
contribute to the suppressive effect of LEVL irradiation on the
Th2 response. Further studies are needed to clarify this issue.
Immunosuppression induced by UVB irradiation has been
intensively investigated for many years. To date, three
photoreceptors have been identified: DNA, trans-urocanic
acid, and membrane lipid (Ullrich, 2005). Although
three photoreceptors contribute to immunosuppression,
Table 1. Known effects of IL-18 which might
contribute to immunomodulation by low-energy
visible light
A potent proinflammatory cytokine in innate immunity
Enhances IL-12-driven Th1 immune response
Stimulates Th2 immune response in the absence of IL-12
Promotes migration of epidermal LC into draining lymph nodes by a
TNF-a and IL-1b-dependent mechanism
Upregulates the expression of MHC class II and costimulating molecules
on human DCs
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UVB-induced DNA damage is considered to be the most
critical event. Local and systemic immunosuppression was
achieved by modulation of APC function, production of
soluble immunomodulatory mediators, and induction of T-
regulatory cells (Ullrich, 2005). Thus, a shift in the T-cell
differentiation from Th1 to Th2 cells and promotion of the
development of AD-like lesions in NC/Nga mice were
observed following UVB irradiation (Simon et al., 1990;
Mutou et al., 2007). On the other hand, the photoreceptor for
LEVL irradiation is cytochrome c oxidase in mitochondria.
The major events following LEVL irradiation are a change in
the redox properties of respiratory chain components and
production of reactive oxygen species (Karu, 1999; Lavi et al.,
2003). Obviously, owing to totally different photoreceptors
and the following events, it is not surprising for UVB and
LEVL irradiation to have different immunomodulatory effects.
However, a review of the literature found several reports that
deserve special attention. First, Teunissen and co-workers
reported that after UVB irradiation, two separate subpopula-
tions of LCs were distinguished (Nakagawa et al., 1999). One
group was apoptotic and mediated immunosuppression,
whereas the second group could immunopotentiate the
response by enhancing the upregulation of costimulatory
molecules and the production of proinflammatory cytokines.
Second, Lee and co-workers reported increased IL-18
production in a human keratinocyte cell line by UVB
irradiation, which required reactive oxygen intermediates
and AP-1 signaling (Cho et al., 2002). We wonder whether
UVB irradiation may also simultaneously induce a weaker
immunopotentiating pathway that may be comparable to that
induced by LEVL irradiation in addition to its predominant
immunosuppressive effect. This issue deserves further
clarification.
In summary, we have provided evidence for immunomo-
dulatory effects of LEVL irradiation. As epicutaneous sensi-
tization is an important route for protein allergen sensitization
in atopic diseases, these results will help us elucidate the
regulation of allergen sensitization and develop a useful
strategy to prevent allergen sensitization.
MATERIALS AND METHODS
Mice and reagents
Six- to ten-week-old female BALB/c and C57BL/6 mice were
purchased from the animal center of National Taiwan University
College of Medicine and kept in a specific-pathogen-free environ-
ment. All animal experiments were approved by the animal care
committee of the Medical College of National University. OVA
(Grade V) and Pam3CSK4 were purchased from Sigma-Aldrich
(St Louis, MO) and InvivoGen (Carlsbad, CA), respectively. Capture
and biotin-conjugated detecting antibodies for IFN-g and IL-5 used
in the ELISA were from PharMingen (San Diego, CA). Streptavidin-
alkaline phosphatase was purchased from Southern Biotechnology
(Birmingham, AL). The murine IL-13 ELISA kit purchased from R&D
Systems (Minneapolis, MN) was used for determination of the IL-13
content of supernatants. Antibodies used for flow cytometry were all
purchased from PharMingen or e-Bioscience (San Diego, CA).
Antibody-conjugated microbeads used for isolating cells were all
purchased from Miltenyi (Bergisch Gladbach, Germany).
LEVL irradiation and immunization
Mice were immunized as previously described (Wang et al., 2006).
Briefly, 20ml of OVA (100mgml1) was placed on the disc of a Finn
chamber (Epitest, Tuusula, Finland). This disk was applied to an area
of shaved skin on the back of a mouse. For each course of
immunization, freshly prepared patches were applied on days 1–5.
The LEVL-irradiated group received anesthesia by intraperitoneal
injection, were irradiated for 20minutes with a visible red (633 nm)
light-emitting diode-based system, at 4mW power at a distance of
10 cm and immediately received the patch. For the sham-irradiated
group, mice received a similar treatment but without LEVL
irradiation.
Cytokine determination in supernatants of lymph node cell
reactivation culture
Ten days after the start of the immunization course, mice were killed,
and axillary, subscapular, and inguinal LNs were harvested. Pooled
LN cells (1 106) were cultured in the presence or absence of
100mgml1 OVA. Supernatants were harvested 48 hour later and
stored at 801C. IFN-g, IL-5, and IL-13 content of supernatants was
measured for each by a standard sandwich ELISA. The limit of
detection for IL-5 and IL-13 was 10 pgml1 and for IFN-g was
50 pgml1. OVA-specific cytokine production was calculated by
subtraction of cytokine production measured in the absence of OVA
from that in the presence of OVA.
Total RNA extraction, cDNA preparation, and quantitative
real-time PCR
Skin was obtained 8 and 24 hours after patch immunization.
Draining LNs were obtained 72 hours after patch immunization.
They were frozen with liquid nitrogen and soaked in 1ml TRIzol
Reagent (Invitrogen, Carlsbad, CA). After homogenization, the total
RNA was extracted, cDNA was synthesized, and the expression of
mRNA of IFN-g, IFN-a, IFN-b, IL-4, IL-6, IL-10, IL-12 (p35), IL-12
(p40), IL-18, TGF-b, IL-1a, IL-1b, and TNF-a was determined by
quantitative real-time PCR according to the manufacturer’s instruc-
tions. Each sample was analyzed in triplicate. The relative cytokine
mRNA expression level of each sample was normalized according to
its b-actin expression.
Flow cytometry analysis
Skin-draining LNs (axillary, subscapular, and inguinal) were
excised 24 or 96hours after the start of the immunization
course. LN cell suspensions were prepared by digestion with
2.5mgml1 collagenase for 30min at 371C, and the tissue was
ground up and resuspended in HBSS containing 10mM EDTA
for another 5minutes. The CD11cþ cells were isolated by anti-
CD11c microbeads. Cells were stained by various combinations of
antibodies (CD11c-APC (HL3), CD24-biotin (M1/69), CD40-biotin
(3/23), CD54-biotin (3E2), CD80-biotin (16-10A1), CD86-biotin
(PO3), MHC class II-biotin (2G9)) and their isotype controls
with or without subsequent staining with streptavidin-FITC.
Intracellular staining of anti-Langerin (CD207)-PE was also
performed.
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